Precision medicine for Parkinson’s disease: The subtyping challenge

Overview of attention for article published in Frontiers in Aging Neuroscience, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 21 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 21,460 followers.

https://t.co/vTM977DwKA

28 Dec 2022

Reply Repost Favourite

New perspective explores subtyping challenge in the pursuit of precision medicine for #Parkinsons, from @flyerliar @bkfiske & Todd Sherer @MichaelJFoxOrg; "Indeed, PD will require a consensus molecular staging similar to what has been done for #Alzheim

21 Dec 2022

Reply Repost Favourite

Precision medicine for Parkinson’s disease: The subtyping challenge https://t.co/WKFeHapL0o

17 Dec 2022

Reply Repost Favourite

This is a key focus of our R&D these days - using PPMI data and developing new biomarkers of activity in pathways key to PD etiology and progression will be key to selecting the right patients for trials, and validating that drugs test the intend

04 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.